England: NICE Finds Its Advice Can Cut Drug Appraisal Times By Three Months

 
• By Neena Brizmohun

The health technology assessment institute said its “unique insights” could help companies effectively prepare for their appraisals, potentially streamlining their path through the process, and helping to get innovative technologies to patients faster.

General stock - UK pounds and prescription drugs
NICE examines the cost-effectiveness of drugs for use in England (Shutterstock)

More from Health Technology Assessment

More from Pink Sheet